{
     "PMID": "27468164",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170908",
     "LR": "20180111",
     "IS": "1879-1379 (Electronic) 0022-3956 (Linking)",
     "VI": "82",
     "DP": "2016 Nov",
     "TI": "Involvement of PI3K/Akt/GSK-3beta and mTOR in the antidepressant-like effect of atorvastatin in mice.",
     "PG": "50-7",
     "LID": "10.1016/j.jpsychires.2016.07.004 [doi] S0022-3956(16)30133-9 [pii]",
     "AB": "Atorvastatin is a cholesterol-lowering statin that has been shown to exert several pleiotropic effects in the nervous system as a neuroprotective and antidepressant-like agent. Antidepressant-like effect of atorvastatin in mice is mediated by glutamatergic and serotoninergic receptors, although the precise intracellular signaling pathways involved are unknown. PI3K/Akt/GSK-3beta/mTOR signaling pathway has been associated to neurobiology of depression and seems to be modulated by some pharmacological antidepressant strategies. The present study investigated the participation of the PI3K/Akt/GSK-3beta/mTOR signaling pathway in the antidepressant-like effect of an acute atorvastatin treatment in mice. Atorvastatin sub-effective (0.01 mg/kg) or effective (0.1 mg/kg) doses in the tail suspension test (TST) was administered orally alone or in combination with PI3K, GSK-3beta or mTOR inhibitors. The administration of PI3K inhibitor, LY294002 (10 nmol/site, i.c.v) completely prevented the antidepressant-like effect of atorvastatin (0.1 mg/kg, p.o.). The participation of GSK-3beta in the antidepressant-like effect of atorvastatin was demonstrated by co-administration of a sub-effective dose of atorvastatin (0.01 mg/kg, p.o.) with AR-A014418 (0.01 mug/site, i.c.v., a selective GSK-3beta inhibitor) or with lithium chloride (10 mg/kg, p.o., a non-selective GSK-3beta inhibitor). The mTOR inhibitor, rapamycin (0.2 nmol/site, i.c.v.) was also able to prevent atorvastatin (0.1 mg/kg, p.o.) antidepressant-like effect. These behavioral findings were supported by neurochemical observations, as atorvastatin treatment increased the immunocontent of the phosphorylated isoforms of Akt, GSK-3beta and mTOR in the hippocampus of mice. Taken together, our results suggest an involvement of the PI3K/Akt/GSK-3beta/mTOR signaling pathway in the antidepressant-like effect of atorvastatin in mice.",
     "CI": [
          "Copyright (c) 2016. Published by Elsevier Ltd."
     ],
     "FAU": [
          "Ludka, Fabiana Kalyne",
          "Constantino, Leandra Celso",
          "Dal-Cim, Tharine",
          "Binder, Luisa Bandeira",
          "Zomkowski, Andrea",
          "Rodrigues, Ana Lucia S",
          "Tasca, Carla Ines"
     ],
     "AU": [
          "Ludka FK",
          "Constantino LC",
          "Dal-Cim T",
          "Binder LB",
          "Zomkowski A",
          "Rodrigues AL",
          "Tasca CI"
     ],
     "AD": "Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil; Curso de Farmacia, Universidade do Contestado, 89460-000, Canoinhas, SC, Brazil. Electronic address: fabianakalyne@hotmail.com. Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil. Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil. Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil; Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil; Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil; Programa de Pos-graduacao em Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil; Programa de Pos-graduacao em Neurociencias, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade, 88040-900, Florianopolis, SC, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160707",
     "PL": "England",
     "TA": "J Psychiatr Res",
     "JT": "Journal of psychiatric research",
     "JID": "0376331",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Enzyme Inhibitors)",
          "0 (Immunosuppressive Agents)",
          "48A5M73Z4Q (Atorvastatin Calcium)",
          "EC 2.7.1.- (Phosphatidylinositol 3-Kinases)",
          "EC 2.7.1.1 (TOR Serine-Threonine Kinases)",
          "EC 2.7.1.1 (mTOR protein, mouse)",
          "EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta)",
          "EC 2.7.11.1 (Oncogene Protein v-akt)",
          "W36ZG6FT64 (Sirolimus)"
     ],
     "SB": "IM",
     "MH": [
          "Analysis of Variance",
          "Animals",
          "Antidepressive Agents/*therapeutic use",
          "Atorvastatin Calcium/*therapeutic use",
          "Depression/*drug therapy",
          "Disease Models, Animal",
          "Enzyme Inhibitors/pharmacology",
          "Exploratory Behavior/drug effects",
          "Glycogen Synthase Kinase 3 beta/metabolism",
          "Hindlimb Suspension/methods",
          "Immunosuppressive Agents/pharmacology",
          "Male",
          "Mice",
          "Oncogene Protein v-akt/metabolism",
          "Phosphatidylinositol 3-Kinases/*metabolism",
          "Signal Transduction/*drug effects",
          "Sirolimus/pharmacology",
          "TOR Serine-Threonine Kinases/*metabolism",
          "Time Factors"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Antidepressant-like",
          "*Atorvastatin",
          "*GSK-3beta",
          "*PI3K/Akt",
          "*Tail suspension test",
          "*mTOR"
     ],
     "EDAT": "2016/07/29 06:00",
     "MHDA": "2017/09/09 06:00",
     "CRDT": [
          "2016/07/29 06:00"
     ],
     "PHST": [
          "2015/12/16 00:00 [received]",
          "2016/03/30 00:00 [revised]",
          "2016/07/05 00:00 [accepted]",
          "2016/07/29 06:00 [entrez]",
          "2016/07/29 06:00 [pubmed]",
          "2017/09/09 06:00 [medline]"
     ],
     "AID": [
          "S0022-3956(16)30133-9 [pii]",
          "10.1016/j.jpsychires.2016.07.004 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Psychiatr Res. 2016 Nov;82:50-7. doi: 10.1016/j.jpsychires.2016.07.004. Epub 2016 Jul 7.",
     "term": "hippocampus"
}